Literature DB >> 23239843

Subjective responses to oral tobacco products: scale validation.

Dorothy K Hatsukami1, Yan Zhang, Richard J O'Connor, Herb H Severson.   

Abstract

INTRODUCTION: Several noncombusted oral tobacco products have been introduced that are primarily marketed to cigarette smokers. An important component of evaluating these products involves assessment of subjective responses to the product. To date, few studies have been undertaken to examine the validity of subjective response questionnaires for oral tobacco products. The goal of this study is to examine the extent subjective responses to a product are related to product preference and extent of product use.
METHODS: Data from a study examining oral tobacco product preference were used. Smokers were asked to sample a variety of oral tobacco products that differed in formulation (snus versus dissolvables) and dose of nicotine. At the end of the sampling period, subjects were asked to choose the product that they would use to completely substitute for cigarettes for the next 2 weeks. During the sampling period, subjects completed a Product Evaluation Scale (PES) that describes subjective responses to the product. During the treatment phase, they kept record of amount of product use.
RESULTS: Subjective responses to the product on the PES were related to product choice and to some extent, the amount of product use. Product choice was associated with different characteristics of the product and smoker needs.
CONCLUSION: The PES may be a useful tool for the evaluation or oral tobacco products.

Entities:  

Mesh:

Year:  2012        PMID: 23239843      PMCID: PMC3682844          DOI: 10.1093/ntr/nts265

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  14 in total

1.  Oral tobacco products: preference and effects among smokers.

Authors:  Dorothy K Hatsukami; Joni Jensen; Amanda Anderson; Berry Broadbent; Sharon Allen; Yan Zhang; Herb Severson
Journal:  Drug Alcohol Depend       Date:  2011-04-23       Impact factor: 4.492

2.  Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire.

Authors:  Joseph C Cappelleri; Andrew G Bushmakin; Christine L Baker; Elizabeth Merikle; Abayomi O Olufade; David G Gilbert
Journal:  Addict Behav       Date:  2006-07-27       Impact factor: 3.913

3.  Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.

Authors:  Jennifer N Gray; Alison B Breland; Michael Weaver; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2008-09       Impact factor: 4.244

Review 4.  Measures for assessing subjective effects of potential reduced-exposure products.

Authors:  Karen Hanson; Richard O'Connor; Dorothy Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

5.  Evaluating oral noncombustible potential-reduced exposure products for smokers.

Authors:  Melissa D Blank; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2010-02-16       Impact factor: 4.244

6.  Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.

Authors:  Michael Kotlyar; Louise A Hertsgaard; Bruce R Lindgren; Joni A Jensen; Steven G Carmella; Irina Stepanov; Sharon E Murphy; Stephen S Hecht; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-10       Impact factor: 4.254

Review 7.  Principles of laboratory assessment of drug abuse liability and implications for clinical development.

Authors:  Lawrence P Carter; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

8.  Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers.

Authors:  C O Cobb; M F Weaver; T Eissenberg
Journal:  Tob Control       Date:  2009-04-02       Impact factor: 7.552

9.  Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.

Authors:  M Irene Mendoza-Baumgart; Ozlem E Tulunay; Stephen S Hecht; Yan Zhang; Sharon Murphy; Chap Le; Joni Jensen; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2007-12       Impact factor: 4.244

10.  US smokers' reactions to a brief trial of oral nicotine products.

Authors:  Richard J O'Connor; Kaila J Norton; Maansi Bansal-Travers; Martin C Mahoney; K Michael Cummings; Ron Borland
Journal:  Harm Reduct J       Date:  2011-01-10
View more
  23 in total

1.  Acute effects of snus in never-tobacco users: a pilot study.

Authors:  Jenny E Ozga; Nicholas J Felicione; Daniel Elswick; Melissa D Blank
Journal:  Am J Drug Alcohol Abuse       Date:  2016-12-08       Impact factor: 3.829

2.  Using Electrophysiological Measures to Assess the Consumer Acceptability of Smokeless Tobacco Products.

Authors:  George A Buzzell; Babita Das; Raul Cruz-Cano; Lizette E Nkongho; Azieb W Kidanu; Hyoshin Kim; Pamela I Clark; Craig G McDonald
Journal:  Nicotine Tob Res       Date:  2016-02-29       Impact factor: 4.244

3.  Effect of e-cigarette flavors on nicotine delivery and puffing topography: results from a randomized clinical trial of daily smokers.

Authors:  Natalie Voos; Danielle Smith; Lisa Kaiser; Martin C Mahoney; Clara M Bradizza; Lynn T Kozlowski; Neal L Benowitz; Richard J O'Connor; Maciej L Goniewicz
Journal:  Psychopharmacology (Berl)       Date:  2019-11-26       Impact factor: 4.530

4.  Acceptability of electronic nicotine delivery systems (ENDS) among HIV positive smokers.

Authors:  Jessica Yingst; Jonathan Foulds; John Zurlo; Michael B Steinberg; Thomas Eissenberg; Ping Du
Journal:  AIDS Care       Date:  2019-11-07

5.  Randomized within-subject trial to evaluate smokers' initial perceptions, subjective effects and nicotine delivery across six vaporized nicotine products.

Authors:  Natalie Voos; Lisa Kaiser; Martin C Mahoney; Clara M Bradizza; Lynn T Kozlowski; Neal L Benowitz; Richard J O'Connor; Maciej L Goniewicz
Journal:  Addiction       Date:  2019-04-25       Impact factor: 6.526

6.  The role of subjective responses in electronic cigarette uptake and substitution in adult smokers.

Authors:  Mari S Gades; Ashley Petersen; Ellen Meier; Bruce R Lindgren; Richard J O'Connor; Peter G Shields; Dorothy Hatsukami
Journal:  Drug Alcohol Depend       Date:  2020-04-25       Impact factor: 4.492

7.  Evaluating the utility of the modified cigarette evaluation questionnaire and cigarette purchase task for predicting acute relative reinforcing efficacy of cigarettes varying in nicotine content.

Authors:  Cecilia L Bergeria; Sarah H Heil; Danielle R Davis; Joanna M Streck; Stacey C Sigmon; Janice Y Bunn; Jennifer W Tidey; Chris A Arger; Derek D Reed; Thomas Gallagher; John R Hughes; Diann E Gaalema; Maxine L Stitzer; Stephen T Higgins
Journal:  Drug Alcohol Depend       Date:  2019-02-13       Impact factor: 4.492

8.  Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content.

Authors:  Christopher A Arger; Sarah H Heil; Stacey C Sigmon; Jennifer W Tidey; Maxine L Stitzer; Diann E Gaalema; Hanna J Durand; Janice Y Bunn; Elizabeth K Ruggieri; Stephen T Higgins
Journal:  Exp Clin Psychopharmacol       Date:  2017-12       Impact factor: 3.157

9.  The Impact of E-liquid Propylene Glycol and Vegetable Glycerin Ratio on Ratings of Subjective Effects, Reinforcement Value, and Use in Current Smokers.

Authors:  Tracy T Smith; Bryan W Heckman; Amy E Wahlquist; K Michael Cummings; Matthew J Carpenter
Journal:  Nicotine Tob Res       Date:  2020-04-21       Impact factor: 4.244

10.  Perceived Health Risks of Snus and Medicinal Nicotine Products.

Authors:  Dorothy K Hatsukami; R I Vogel; Herb H Severson; Joni A Jensen; Richard J O'Connor
Journal:  Nicotine Tob Res       Date:  2015-09-18       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.